News & Contact - Allinky Biopharma

ALLINKY
Biopharma
ALLINKY Biopharma
Go to content


Shaping the future of Medicine



News
  • Allinky's founder Prof. Dr. Juan Jesús Pérez presents latest results on Allinky's NASH program at the World Preclinical Congress
  • The Spanish Science & Technology Ministry grants two new R&D projects to Allinky
  • Allinky's General Manager participates as speaker at BioSpain 2018
  • Allinky showcases its latest developments on Oncology and Inflammation at BioEurope Berlin (Nov. 2017)
  • Plos One publishes latest results on Allinky's allosteric modulators of MAP Kinases (+)
  • Allinky accepts invitation to participate in the 2017 fourteenth annual Anglonordic Life Science Conference in London.
  • Journal of Alzheimer's Disease publishes latest results on Allinky's protein-protein interaction inhibitors (+)
  • The EU Eurostars Progam grants Allinky with a new project on Oncology
  • Cell publishes latest results from Allinky's founder Dr. Torres Aleman (+)
  • Allinky's General Manager participates as speaker in the 3rd European Neurotech & Investing & Partnering Summit in Geneva
  • Nature Reviews publishes latest results from Allinky's founder Dr. Torres-Aleman: "The many faces of insulin-like signalling in the brain." (+)




Faraday 7, ES-28049 Madrid (Spain)
Back to content